Heritage Bio Labs
Research Library
Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.
Find articles
All articles
Showing 49–60 of 411 articles
- Interpret the evidence
What three dental nerve cases can tell us about a mixture
BPC-157 is a synthetic 15-amino-acid peptide. TB-500 can refer to a synthetic acetylated seven-amino-acid fragment of thymosin beta-4, although an experimental report needs to identify what its authors used.
BPC-157 / TB-5002 sources (2012, 2026)
- Interpret the evidence
What the four groups in a rat tendon study could compare
BPC-157 is a synthetic 15-amino-acid peptide. TB-500 commonly denotes an acetylated seven-amino-acid fragment of thymosin beta-4. In July 2026, investigators used BPC-157 and a reagent they called TB-500 to ask whether giving them together changed healing after Achilles tendon repair in rats.
BPC-157 / TB-5002 sources (2012, 2026)
- Interpret the evidence
Why collagen appearance and tendon strength can tell different stories
BPC-157 is a synthetic 15-amino-acid peptide. TB-500 generally refers to an acetylated seven-amino-acid fragment of thymosin beta-4. In a 2026 study of rat Achilles tendons, the investigators used BPC-157 and a supplier reagent labeled TB-500.
BPC-157 / TB-5002 sources (2012, 2026)
- Understand the science
Why the exact sequence matters when studying the pair
BPC-157 is a synthetic 15-amino-acid peptide. The term TB-500 can refer to Ac-LKKTETQ, a synthetic acetylated fragment of the longer molecule thymosin beta-4. The exact sequence matters when scientists compare a study of one ingredient with studies of the two together.
BPC-157 / TB-5003 sources (2012, 2026)
- Understand the science
How the 2026 compounding policy treats single ingredients
BPC-157 is a synthetic 15-amino-acid peptide, and TB-500 is defined in an October 2026 U.S. policy as an acetylated seven-amino-acid fragment related to thymosin beta-4. The policy gives each substance its own identity and addresses a specific question about compounding under federal law.
BPC-157 / TB-5002 sources (2026)
- Interpret the evidence
What an older knee chart review actually compared
BPC-157 is a synthetic 15-amino-acid peptide. TB-500 usually refers to an acetylated seven-amino-acid fragment of thymosin beta-4. An older 2021 knee report described BPC-157 together with a substance called TB4.
BPC-157 / TB-5002 sources (2012, 2021)
- Check methods and identity
The trials designed to test cagrilintide on its own
Cagrilintide is an investigational, long-acting peptide that activates receptors for amylin and calcitonin. It is often discussed alongside semaglutide because they are being studied together as CagriSema.
Cagrilintide3 sources (2025, 2026)
- Interpret the evidence
Why REIMAGINE 2 compared cagrilintide with semaglutide
Cagrilintide is an investigational long-acting peptide modeled on amylin. Semaglutide acts on the GLP-1 receptor. REIMAGINE 2 studied the two peptides alone and together in people with type 2 diabetes and overweight or obesity.
Cagrilintide2 sources (2025, 2026)
- Interpret the evidence
What a cagrilintide combination changed in a basal insulin trial
Cagrilintide is an investigational peptide designed to act like the hormone amylin for longer. In the 2026 REIMAGINE 3 study, researchers asked what changed when the cagrilintide–semaglutide combination, called CagriSema, was added to basal insulin in adults with type 2 diabetes.
Cagrilintide1 source (2026)
- Interpret the evidence
What the Japan and Taiwan CagriSema trial adds to the evidence
Cagrilintide is a long-acting investigational amylin-based peptide. CagriSema pairs it with the GLP-1 receptor agonist semaglutide. In REDEFINE 5, researchers examined whether the combination produced a different weight change from semaglutide alone in adults studied in Japan and Taiwan.
Cagrilintide1 source (2026)
- Understand the science
How REDEFINE 1 researchers studied blood pressure
Cagrilintide is an investigational amylin-based peptide studied alone and as part of CagriSema with semaglutide. An analysis published in December 2025 examined blood pressure readings collected in the REDEFINE 1 weight-management trial.
Cagrilintide3 sources (2023–2026)
- Explore study findings
Why the four arms of REDEFINE 1 mattered for cagrilintide
Cagrilintide is an investigational long-acting amylin-based peptide. The older primary REDEFINE 1 report matters for the specific question of cagrilintide alone because the large weight-management trial included a separate cagrilintide arm alongside the fixed combination.
Cagrilintide3 sources (2025, 2026)
Browse by product
- A4 Amyloid Beta6 articles
- ACE-0316 articles
- ACE-0836 articles
- Adipotide6 articles
- AICAR6 articles
- AOD-96046 articles
- ARA-2906 articles
- BPC-1576 articles
- BPC-157 / TB-5006 articles
- Cagrilintide7 articles
- CJC-1295 (No DAC) / GHRP-26 articles
- CJC-1295 (No DAC) / GHRP-66 articles
- CJC-1295 (No DAC) / Ipamorelin6 articles
- CJC-1295 No DAC6 articles
- CJC-1295 With DAC6 articles
- DSIP6 articles
- Epitalon6 articles
- Follistatin 3156 articles
- Follistatin 3446 articles
- Fragment 176-1916 articles
- GHK-Cu6 articles
- GHRP-26 articles
- GHRP-66 articles
- GLOW 2 Blend6 articles
- GLOW Blend6 articles
- GLP-1 SEMA6 articles
- GLP-2 TIRZ6 articles
- Glutathione6 articles
- HCG6 articles
- Hexarelin6 articles
- Human Relaxin-26 articles
- IGF-1 DES 1,36 articles
- IGF-1 Human6 articles
- IGF-2 LR36 articles
- IGF-DES 1,36 articles
- IGF-LR36 articles
- Ipamorelin6 articles
- Kisspeptin-106 articles
- KLOW Blend6 articles
- KPV6 articles
- Lipopeptide6 articles
- Liraglutide6 articles
- Melanotan II5 articles
- MGF6 articles
- MOTS-C6 articles
- MSC Exosomes6 articles
- Myostatin6 articles
- Myostatin HMP (GDF8)6 articles
- Oxytocin7 articles
- PEG-MGF6 articles
- Pinealon6 articles
- PT-1416 articles
- RETA / IGF-1 LR36 articles
- RETA GLP-36 articles
- Selank6 articles
- SEMA / IGF-1 LR36 articles
- Semax6 articles
- Sermorelin6 articles
- SLU-PP-3326 articles
- SNAP-86 articles
- Survodutide7 articles
- TB-5006 articles
- Tesamorelin6 articles
- Thymosin Alpha-16 articles
- TIRZ / IGF-1 LR36 articles
- TIRZ GLP-26 articles
- Trevogrumab6 articles
- Triptorelin GnRH6 articles
